Package 60505-6271-1

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "3233ecb7-1619-72ec-e138-4bfd17267f5a", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0360505627110"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["a6a5ca37-37e8-ab65-bc0b-9c0682ab52f7"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6271-1)", "package_ndc": "60505-6271-1", "marketing_start_date": "20240123"}], "brand_name": "Azacitidine", "product_id": "60505-6271_3233ecb7-1619-72ec-e138-4bfd17267f5a", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "60505-6271", "generic_name": "azacitidine", "labeler_name": "Apotex Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA215905", "marketing_category": "ANDA", "marketing_start_date": "20240123", "listing_expiration_date": "20261231"}